Eric Cohen

678 total citations
21 papers, 411 citations indexed

About

Eric Cohen is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Eric Cohen has authored 21 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Eric Cohen's work include Liver Disease Diagnosis and Treatment (5 papers), Hepatitis C virus research (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Eric Cohen is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Hepatitis C virus research (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Eric Cohen collaborates with scholars based in United States, France and Australia. Eric Cohen's co-authors include G. D. Motykie, José J. Reyna, Juan I. Arcelus, Lukas P. Zebala, Joseph A. Caprini, Nezam H. Afdhal, M. Robert Eichenberger, Henry L. Roberts, Christopher Barnes and Ziad Kanaan and has published in prestigious journals such as Journal of Hepatology, The American Journal of Gastroenterology and Journal of Vascular Surgery.

In The Last Decade

Eric Cohen

20 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Cohen United States 9 105 92 92 87 84 21 411
Wanmu Xie China 12 254 2.4× 82 0.9× 23 0.3× 78 0.9× 75 0.9× 78 541
Takayuki Jujo Japan 13 256 2.4× 50 0.5× 22 0.2× 83 1.0× 39 0.5× 63 545
Chiara Sonnino Italy 12 320 3.0× 198 2.2× 18 0.2× 144 1.7× 111 1.3× 21 542
Changming Xiong China 14 203 1.9× 37 0.4× 19 0.2× 63 0.7× 49 0.6× 30 441
Wayne W. Zhang United States 14 169 1.6× 201 2.2× 13 0.1× 40 0.5× 78 0.9× 46 562
Gonzalo Barge‐Caballero Spain 13 244 2.3× 216 2.3× 24 0.3× 121 1.4× 63 0.8× 74 479
Avital Avriel Israel 10 53 0.5× 59 0.6× 131 1.4× 113 1.3× 45 0.5× 22 422
Joke Konings Netherlands 11 54 0.5× 26 0.3× 9 0.1× 24 0.3× 33 0.4× 18 291
Sylwia Sławek-Szmyt Poland 13 180 1.7× 52 0.6× 11 0.1× 48 0.6× 89 1.1× 47 425
Yukio Nishida Japan 10 549 5.2× 492 5.3× 24 0.3× 51 0.6× 77 0.9× 16 784

Countries citing papers authored by Eric Cohen

Since Specialization
Citations

This map shows the geographic impact of Eric Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Cohen more than expected).

Fields of papers citing papers by Eric Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Cohen. The network helps show where Eric Cohen may publish in the future.

Co-authorship network of co-authors of Eric Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Cohen. A scholar is included among the top collaborators of Eric Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Cohen. Eric Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Eric & James H. Lewis. (2025). Modifying Hy’s Law and eDISH for the modern idiosyncratic DILI era. Expert Opinion on Drug Metabolism & Toxicology. 21(10). 1159–1168.
2.
Boinpally, Ramesh, Jonathan Smith, Eric Cohen, & Joel M. Trugman. (2025). Milk and plasma pharmacokinetics of single‐dose ubrogepant in healthy lactating women. Headache The Journal of Head and Face Pain. 65(7). 1190–1197. 1 indexed citations
3.
Cohen, Eric, Meenal Patwardhan, David Alpers, et al.. (2024). Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative. Drug Safety. 47(4). 301–319. 7 indexed citations
4.
Xiong, Hao, Cindy Zadikoff, Qingbo Li, et al.. (2024). Safety, Tolerability, and Pharmacokinetics of Single Doses of Exidavnemab (BAN0805), an Anti‐α‐Synuclein Antibody, in Healthy Western, Caucasian, Japanese, and Han Chinese Adults. The Journal of Clinical Pharmacology. 64(11). 1432–1442. 2 indexed citations
6.
Poordad, Fred, Michael Bennett, Thomas Sepe, et al.. (2019). Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct‐acting antiviral therapy. Journal of Medical Virology. 91(7). 1307–1312. 3 indexed citations
7.
Shafran, Stephen D., Douglas W. Shaw, Kosh Agarwal, et al.. (2017). Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ IIIII). Journal of Viral Hepatitis. 25(2). 118–125. 9 indexed citations
9.
Chan, Edie Y., Renuka Bhattacharya, Sheila Eswaran, et al.. (2014). Outcomes after combined liver–kidney transplant vs. kidney transplant followed by liver transplant. Clinical Transplantation. 29(1). 60–66. 2 indexed citations
11.
Kanaan, Ziad, N. Shesh, M. Robert Eichenberger, et al.. (2012). Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Human Mutation. 33(3). 551–560. 108 indexed citations
12.
Cohen, Eric, et al.. (2012). Tongue Ulcer in a Liver Transplant Recipient on a New Immunosuppressive Regimen. American Journal of Transplantation. 12(4). 1057–1059. 2 indexed citations
13.
Kanaan, Ziad, N. Shesh, M. Robert Eichenberger, et al.. (2012). Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Human Mutation. 33(5). 899–899. 6 indexed citations
14.
Giorgio, Massimo De, Stefano Vezzoli, Eric Cohen, et al.. (2010). Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transplantation. 16(4). 503–512. 34 indexed citations
15.
Cohen, Eric & Nezam H. Afdhal. (2010). Ultrasound-based Hepatic Elastography. Journal of Clinical Gastroenterology. 44(9). 637–645. 33 indexed citations
16.
Cohen, Eric, Michael J. Goldberg, Steven Y. Chang, et al.. (2004). MICRO-ARCHITECTURAL ALTERATIONS IN ENDOSCOPICALLY-NORMAL MUCOSA PROVIDES ACCURATE RISK STRATIFICATION FOR COLORECTAL NEOPLASIA. The American Journal of Gastroenterology. 99. S326–S326. 1 indexed citations
17.
Rodier, G., et al.. (2003). [Progression of cerebral venous thromboses. A retrospective study].. PubMed. 32(16). 728–33. 1 indexed citations
18.
Motykie, G. D., Lukas P. Zebala, Joseph A. Caprini, et al.. (2000). A Guide to Venous Thromboembolism Risk Factor Assessment. Journal of Thrombosis and Thrombolysis. 9(3). 253–262. 135 indexed citations
19.
Caprini, Joseph A., Juan I. Arcelus, José J. Reyna, et al.. (1999). Deep vein thrombosis outcome and the level of oral anticoagulation therapy. Journal of Vascular Surgery. 30(5). 805–812. 17 indexed citations
20.
Cohen, Eric, et al.. (1991). The effect of in vitro irradiation on human NK cell activity. A preliminary report.. PubMed. 22(4-5). 243–54. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026